USE OF PROCEEDS
We estimate that the net proceeds from our issuance and sale of 30,000,000 shares of common stock in this offering, after deducting
underwriting discounts and commissions and estimated offering expenses payable by us, will be approximately $208.6 million (or approximately $239.9 million if the underwriters exercise their option to purchase additional shares in full).
We expect to use the net proceeds of this offering for general corporate purposes, which we expect to include funding working capital and
growth initiatives. At this time, we have not specifically identified a large single use for which we intend to use the net proceeds, and, accordingly, we are not able to allocate the net proceeds among any potential uses in light of the variety of
factors that will impact how such net proceeds will ultimately be utilized by us. As a result, our management will retain broad discretion over the use of the net proceeds from this offering.
Pending use of the proceeds from this offering, we intend to invest the proceeds in short-term, investment-grade and interest-bearing
instruments or money market funds.